Clinical Trial Update: A Single Dose Trial in Healthy Caucasians and Japanese Subjects Investigating the Pharmacokinetics of Somatropin [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetic study of somatropin in healthy Caucasian and Japanese subjects has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Growth Hormone Deficiency

Drugs mentioned

• Somatropin (somatropin)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Growth Hormone Disorder, Adult Growth Hormone Deficiency | Phase 1 | Status: COMPLETED